(Q36864593)

16 August 2017

1 reference

title

Bile acid sequestrants and the treatment of type 2 diabetes mellitus (English)

1 reference

16 August 2017

1 reference

1

1 reference

16 August 2017

Folkert Kuipers

2

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

67

1 reference

16 August 2017

1383-1392

1 reference

16 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767100-00001

16 August 2017

0 references

cites work

Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767100-00001

Altered bile acid profiles in duodenal bile and urine in diabetic subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767100-00001

Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle

21 January 2018

1 reference

12 December 2020

Farnesoid X receptor: a new player in glucose metabolism?

1 reference

12 December 2020

Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha.

1 reference

12 December 2020

Stimulation of pancreatic secretion and growth in the rat after feeding cholestyramine

1 reference

12 December 2020

Enhancement of bile acid-induced biliary lipid secretion by streptozotocin in rats: role of insulin deficiency.

1 reference

12 December 2020

Colestilan, a new bile acid-sequestering resin, reduces bodyweight in postmenopausal women who have dieted unsuccessfully

1 reference

12 December 2020

Identification of a nuclear receptor for bile acids

1 reference

12 December 2020

Identification of a nuclear receptor that is activated by farnesol metabolites

1 reference

12 December 2020

Endocrine functions of bile acids

1 reference

12 December 2020

Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts

1 reference

12 December 2020

Oral Antidiabetic Agents

1 reference

12 December 2020

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

1 reference

12 December 2020

Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas

1 reference

12 December 2020

Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids

1 reference

12 December 2020

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

1 reference

12 December 2020

Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats

1 reference

12 December 2020

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

12 December 2020

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Farnesoid X receptor is essential for normal glucose homeostasis

1 reference

12 December 2020

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism

1 reference

12 December 2020

Choosing the right lipid-regulating agent. A guide to selection

1 reference

12 December 2020

Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats.

1 reference

12 December 2020

Regulation of carbohydrate metabolism by the farnesoid X receptor

1 reference

12 December 2020

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

12 December 2020

Bile acids: natural ligands for an orphan nuclear receptor

1 reference

12 December 2020

Effect of streptozotocin-induced diabetes in neonatal rat on bile acid pool changes in adult life: selective sensitivity in females

1 reference

12 December 2020

Nuclear bile acid receptor FXR as pharmacological target: are we there yet?

1 reference

12 December 2020

Treating dyslipidemia of the metabolic syndrome: where's the evidence?

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Bile acid pool changes and regulation of cholate synthesis in experimental diabetes

1 reference

12 December 2020

Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1.

1 reference

12 December 2020

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

1 reference

12 December 2020

Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription

1 reference

12 December 2020

Effect of maternal diabetes on fetal bile acid metabolism in the rat

1 reference

12 December 2020

Specific changes of bile acid metabolism in spontaneously diabetic Wistar rats

1 reference

12 December 2020

Potential regulatory role of the farnesoid X receptor in the metabolic syndrome

1 reference

12 December 2020

Glucose regulates the expression of the farnesoid X receptor in liver

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

1 reference

12 December 2020

Cholesterol biosynthesis in nonketotic diabetics before and during insulin therapy

1 reference

12 December 2020

Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein

1 reference

12 December 2020

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

1 reference

12 December 2020

Experimental steatorrhea induced in man by bile acid sequestrant

1 reference

12 December 2020

Effects of diabetes mellitus on cholesterol metabolism in man.

1 reference

12 December 2020

Studies on cholesterol metabolism in the diabetic rat

1 reference

12 December 2020

Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice.

1 reference

12 December 2020

Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.

1 reference

12 December 2020

Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression

1 reference

12 December 2020

Transient impairment of the adaptive response to fasting in FXR-deficient mice

1 reference

12 December 2020

Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus.

1 reference

12 December 2020

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

1 reference

12 December 2020

10.2165/00003495-200767100-00001

Identifiers

DOI

1 reference

PubMed ID

17600387

Dimensions Publication ID

16 August 2017

1011445363

0 references

Fatcat ID

release_7gvtcpivhfd3biinrex3auzu6q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7gvtcpivhfd3biinrex3auzu6q

24 November 2022

mapped directly with Wikidata item

PubMed ID

17600387

1 reference

PubMed ID

17600387